Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil-Reference-Cited by-同舟云学术

Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil

Published:2019-10-01 Issue:10 Volume:14 Page:e0223210
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Soldi Giselle de Faria Romero^ORCID,Ribeiro Isadora Coutinho,Ahagon Cintia Mayumi,Coelho Luana Portes Ozório,Cabral Gabriela Bastos,Lopes Giselle Ibette Silva López,Ferreira João Leandro de Paula,Brígido Luís Fernando de Macedo,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa.;Nicholas I. PATON;New England Journal Of Medicine,2014

2. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.;Mark A BOYD;The Lancet Hiv,2015

3. High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in São Paulo State, Brazil.;Elaine Monteiro MATSUDA;Aids Research And Human Retroviruses

4. Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens;Luis F. LÓPEZ-CORTÉS;Plos One,2016

5. UNAIDS. Infográficos—Brasil. 2017. Disponível em: . Acessoem: 14 feb. 2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola;Scientific Reports;2024-07-10

2. Exploring Drug-Resistant Mutations in Protease Inhibitors and Subtype Distribution Among HIV-1 Positive Patients in Lorestan Province, Iran;Jundishapur Journal of Microbiology;2024-05-15

3. Exploring Drug-Resistant Mutations in Protease Inhibitors and Subtype Distribution Among HIV-1 Positive Patients in Lorestan Province, Iran;JUNDISHAPUR J MICROB;2024

4. Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations;Pathogens;2022-05-05

5. Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients;Scientific Reports;2022-01-26